Cancer clinical trials in the region Auvergne-Rhône-Alpes
241 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT04924075
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Institut Paoli-Calmettes (Marseille), Hôpital Bicêtre AP-HP (Le Kremlin-Bicêtre), Hôpital Cochin (Paris ), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg) (and 1 more...)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT04868877
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
Systemic Treatment-Naive
Clinique de l'Europe d'Amiens (Amiens), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Albert Calmette de Lille (Lille) (and 7 more...)
Merus
Phase 2
Lung cancer
#NCT04868877
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Clinique de l'Europe d'Amiens (Amiens), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Albert Calmette de Lille (Lille) (and 7 more...)
Merus
Phase 2
Lung cancer
Colon cancer
Rectal cancer
#NCT04868877
Locally Advanced
Metastatic
Clinique de l'Europe d'Amiens (Amiens), Groupe Hospitalier Saint André (Bordeaux), Hôpital Louis Pradel (Bron ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Albert Calmette de Lille (Lille) (and 7 more...)
Merus
Phase 2
Pancreas cancer
#NCT06333314
Adenocarcinoma
Neuroendocrine tumor
Locally Advanced
Metastatic
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Radiotherapy
Centre Léon Bérard (Lyon)
UNICANCER
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Liver and bile duct cancer
#NCT05275478
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif)
Tango Therapeutics
Phase 2
Lung cancer
#NCT05275478
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif)
Tango Therapeutics
Phase 2
Lymphoma
#NCT02875548
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
Targeted therapy
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Centre Henri Becquerel (Rouen ), Hôpital Claude Huriez (Lille) (and 3 more...)
Epizyme, Inc. (Ipsen)
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Locally Advanced
Immunotherapy
Surgery
Immunotherapy
Radiotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard